Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department plans increase breast screenings for young women with (a) neurofibromatosis type 1 (NF1) and (b) other determinants of being at risk of developing breast cancer.

All women with neurofibromatosis type 1 are eligible to begin screening at the age of 40 years old. This is 10 years below the normal screening age of 50 years old. Women can have screenings from a younger age if they have a higher-than-average risk of breast cancer, for example due to family history or an inherited gene such as BRCA.